Affirm
AFRM
$74.52
-4.89%
Affirm Holdings, Inc. is a leading financial technology company specializing in buy now, pay later (BNPL) solutions, offering both zero-interest and interest-bearing installment loans to consumers at the point of sale. As a market leader in the BNPL space, Affirm processes over $36 billion in annual transaction volume and differentiates itself through its transparent, merchant-integrated platform and its focus on interest-bearing loans, which constitute over 70% of its volume. The current investor narrative centers on Affirm's accelerating revenue growth, its recent transition to sustained profitability, and its strategic expansion into new markets and partnerships, while also debating the sustainability of its growth amid rising competition and potential regulatory scrutiny in the consumer credit space.…
AFRM
Affirm
$74.52
Investment Opinion: Should I buy AFRM Today?
Rating: Buy. Affirm's accelerating revenue growth, transition to profitability, and reasonable forward valuation make it an attractive investment. The analyst consensus of Buy with a 16.2% upside to the average target supports this view. The core thesis is that Affirm is a high-growth fintech leader that has proven its ability to monetize its BNPL platform and is now entering a phase of sustained profitability.
Sign up to view all
AFRM 12-Month Price Forecast
The AI model assesses AFRM as bullish with medium confidence. The company's accelerating revenue growth and transition to profitability are strong positive signals, and the forward valuation is reasonable. However, the high beta and regulatory risks introduce uncertainty. The model would upgrade to high confidence if revenue growth sustains above 30% and net margins expand, while a downgrade would occur if growth falls below 20% or credit losses spike.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Affirm's 12-month outlook, with a consensus price target around $91.20 and implied upside of +22.4% versus the current price.
Average Target
$91.20
0 analysts
Implied Upside
+22.4%
vs. current price
Analyst Count
—
covering this stock
Price Range
$55 - $117
Analyst target range
Affirm is covered by 30 analysts, with a consensus recommendation of 'Buy' and a mean recommendation score of 1.68 (where 1 is Strong Buy and 5 is Sell). The average target price is $91.04, which implies an upside of approximately 16.2% from the current price of $78.35. The distribution of ratings is bullish, with recent actions from major firms like Goldman Sachs, JP Morgan, and Wells Fargo reaffirming Buy or Overweight ratings, though Morgan Stanley downgraded to Equal Weight in June 2026. The consensus sentiment is clearly positive, reflecting confidence in Affirm's growth trajectory and profitability improvements.
Bulls vs Bears: AFRM Investment Factors
Affirm presents a compelling growth story with accelerating revenue, sustained profitability, and a reasonable forward valuation. However, the stock's extreme volatility, high leverage, and regulatory risks temper the bullish case. Currently, the bull case has stronger evidence, given the company's fundamental improvements and analyst support. The key tension is whether Affirm can maintain its growth momentum and profitability in the face of rising competition and potential regulatory headwinds. If growth decelerates or credit quality deteriorates, the stock could face significant downside given its high beta and elevated expectations.
Bullish
- Revenue growth accelerating to 32.6% YoY: Q3 FY2026 revenue reached $1.039B, up 32.6% YoY, accelerating from 24.9% in Q4 FY2025. This marks the fourth consecutive quarter of accelerating growth, driven by strong demand for BNPL and successful merchant adoption.
- Transition to sustained GAAP profitability: Affirm reported net income of $102.9M in Q3 FY2026, its third consecutive profitable quarter, with EPS of $0.31. The company has moved from losses in FY2024 to consistent profitability, supported by a net margin of 9.9%.
- Forward PE of 21x below industry average: With a forward PE of 21.07x, Affirm trades at a discount to the typical credit services industry multiple. This suggests the market is pricing in substantial earnings growth, but the valuation remains reasonable relative to growth prospects.
- Strong analyst consensus with 16.2% upside: 30 analysts rate AFRM a Buy with a mean score of 1.68. The average target price of $91.04 implies 16.2% upside from the current $78.35, with a high target of $117, reflecting confidence in the growth trajectory.
Bearish
- Extremely high beta of 3.616: AFRM's beta of 3.616 means it is 3.6 times more volatile than the market. This amplifies downside risk, especially in a rising rate environment, and could lead to outsized losses during market downturns.
- Trailing PE of 432x signals overvaluation: Despite recent profitability, the trailing PE of 432.1x is extremely high. This implies that the market is pricing in massive future earnings growth, leaving little room for error if growth disappoints.
- High debt-to-equity ratio of 2.56: Affirm's debt-to-equity ratio of 2.56 indicates significant leverage, which increases financial risk. Interest expenses of $113.8M in Q3 FY2026 weigh on profitability and could strain cash flows if credit conditions tighten.
- Negative relative strength over 1 year: Despite a 172.7% 1-year price gain, relative strength vs. the S&P 500 is -18.6% over the same period. This suggests the stock has underperformed the market on a risk-adjusted basis, and recent momentum may be fading.
AFRM Technical Analysis
Affirm's stock has demonstrated a robust recovery over the past year, with a 1-year price change of +172.68%, significantly outperforming the S&P 500's +20.37% gain. The current price of $78.35 sits at 78.35% of its 52-week range (between $42.095 and $100.00), indicating the stock is trading closer to its highs but still below the peak. This positioning suggests strong momentum, though the proximity to the high could also imply potential overextension, especially given the stock's high beta of 3.616, which amplifies both upside and downside moves relative to the market.
Beta
3.62
3.62x market volatility
Max Drawdown
-53.9%
Largest decline past year
52-Week Range
$42-$100
Price range past year
Annual Return
-5.3%
Cumulative gain past year
| Period | AFRM Return | S&P 500 |
|---|---|---|
| 1m | -2.0% | +4.0% |
| 3m | +14.1% | +5.3% |
| 6m | +44.1% | +12.6% |
| 1y | -5.3% | +20.1% |
| ytd | +0.7% | +13.3% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
AFRM Fundamental Analysis
Affirm's revenue trajectory is robustly accelerating, with the most recent quarter (Q3 FY2026, ending March 31, 2026) reporting revenue of $1.0388 billion, a 32.64% year-over-year increase. This growth is a continuation of a strong multi-quarter trend: revenue rose from $876.4 million in Q4 FY2025 to $933.3 million in Q1 FY2026, $1.1230 billion in Q2 FY2026, and then to $1.0388 billion in Q3 FY2026, with the YoY growth rate accelerating from 24.9% in Q4 FY2025 to 32.6% in Q3 FY2026. The growth is driven by both the Merchant Network and Virtual Card Network segments, which contributed $268.0 million and $66.5 million respectively in the latest quarter, though the majority of revenue comes from interest-bearing loans. This accelerating growth indicates strong consumer demand for BNPL services and successful merchant adoption, reinforcing Affirm's competitive position in the payments industry.
Quarterly Revenue
$1.0B
2026-03
Revenue YoY Growth
+32.6%
YoY Comparison
Gross Margin
65.9%
Latest Quarter
Free Cash Flow
$787109000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is AFRM Overvalued?
Given that Affirm has positive net income (net income of $102.9 million in the latest quarter), the primary valuation metric selected is the price-to-earnings (PE) ratio. The trailing PE is 432.1x, while the forward PE is 21.07x, a massive gap that implies the market expects significant earnings growth in the coming year. This forward multiple is more reasonable and suggests that the market is pricing in a substantial improvement in profitability, which is supported by the company's recent transition to GAAP profitability and its strong revenue growth. The forward PE of 21.07x is actually below the industry average for credit services companies, which typically trade at higher multiples, indicating that Affirm may be undervalued relative to its growth prospects.
PE
432.1x
Latest Quarter
vs. Historical
High-End
5-Year PE Range 37x~82x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
40.5x
Enterprise Value Multiple
Investment Risk Disclosure
Financial risks are significant due to Affirm's high debt-to-equity ratio of 2.56 and interest expenses of $113.8M in Q3 FY2026. While the company has achieved profitability, its net margin of 9.9% is thin, and any increase in credit losses or funding costs could quickly erode earnings. The trailing PE of 432x leaves no margin for error, and a miss on growth expectations could trigger a sharp de-rating. Additionally, the company's reliance on interest-bearing loans (over 70% of volume) exposes it to consumer credit risk, especially if unemployment rises or the economy slows.
FAQ
The key risks include: 1) Financial risk from high leverage (debt-to-equity of 2.56) and thin net margins (9.9%), which could be hurt by rising credit losses. 2) Market risk from high beta (3.6), making the stock prone to large swings. 3) Competitive risk from established players like Klarna and Afterpay, as well as potential entry by tech giants. 4) Regulatory risk, as BNPL products face increasing scrutiny. The most severe risk is a combination of these factors leading to a sharp de-rating.
The 12-month forecast is bullish, with a base case target of $85-$95 (50% probability), a bull case of $100-$117 (30% probability), and a bear case of $55-$65 (20% probability). The most likely scenario is the base case, where revenue growth remains above 25% and profitability improves, driving the stock to around $91. The key assumption is that Affirm can sustain its growth momentum without major regulatory or competitive disruptions.
AFRM appears undervalued on a forward basis, with a forward PE of 21x, which is below the industry average. However, its trailing PE of 432x is extremely high, reflecting the market's expectation of massive earnings growth. The PS ratio of 6.9x is also elevated. Overall, the market is pricing in strong future growth, but the forward valuation is not excessive, suggesting the stock is fairly valued to slightly undervalued relative to its growth prospects.
AFRM is a good buy for investors with a high risk tolerance and a long-term horizon. The stock offers 16.2% upside to the average analyst target of $91.04, and its forward PE of 21x is reasonable given its growth. However, the high beta of 3.6 and trailing PE of 432x indicate significant risk. It is a good buy if you believe in the BNPL growth story and can tolerate volatility, but not for conservative investors.
AFRM is better suited for long-term investment due to its high growth potential and the time needed for the market to realize its value. The stock's high beta (3.6) makes it too volatile for short-term trading, and its earnings visibility is improving but still uncertain. A minimum holding period of 3-5 years is recommended to ride out volatility and benefit from the company's growth trajectory. Short-term traders may find opportunities, but the risk is elevated.